Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Monson

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2009
A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotidePhillip Kelly, Kathy T Maher, Shern L Chew, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosisHelen L Storr, Andrea M Isidori, John P Monson, et al.
European Journal of Endocrinology|August 17, 2014
The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patientsOskar Ragnarsson, Anders F Mattsson, John P Monson, et al.
European Radiology|January 13, 2009
Imaging in covert ectopic ACTH secretion: a CT pictorial reviewPaul A Sookur, Anju Sahdev, Andrea G Rockall, et al.
The Journal of Clinical Endocrinology and Metabolism|March 26, 2010
Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiencyMaria Kołtowska-Häggström, Mitchell E Geffner, Peter Jönsson, et al.
Clinical Endocrinology|January 5, 2007
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patientsAmar Agha, Dorothy Walker, Les Perry, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 6, 2018
DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISMAmar Agha, Lucy Ann Behan, Hannah Forde, et al.
European Journal of Endocrinology|June 24, 2006
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysisRoger Abs, Ulla Feldt-Rasmussen, Anders F Mattsson, et al.
European Journal of Endocrinology|December 26, 2001
Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's diseaseUlla Feldt-Rasmussen, Roger Abs, Bengt-Ake Bengtsson, et al.
The Journal of Clinical Endocrinology and Metabolism|July 20, 2006
Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacementAntonia M Brooke, Leonila A Kalingag, Farideh Miraki-Moud, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2009
A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotidePhillip Kelly, Kathy T Maher, Shern L Chew, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosisHelen L Storr, Andrea M Isidori, John P Monson, et al.
European Journal of Endocrinology|August 17, 2014
The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patientsOskar Ragnarsson, Anders F Mattsson, John P Monson, et al.
European Radiology|January 13, 2009
Imaging in covert ectopic ACTH secretion: a CT pictorial reviewPaul A Sookur, Anju Sahdev, Andrea G Rockall, et al.
The Journal of Clinical Endocrinology and Metabolism|March 26, 2010
Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiencyMaria Kołtowska-Häggström, Mitchell E Geffner, Peter Jönsson, et al.
Clinical Endocrinology|January 5, 2007
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patientsAmar Agha, Dorothy Walker, Les Perry, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 6, 2018
DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISMAmar Agha, Lucy Ann Behan, Hannah Forde, et al.
European Journal of Endocrinology|June 24, 2006
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysisRoger Abs, Ulla Feldt-Rasmussen, Anders F Mattsson, et al.
European Journal of Endocrinology|December 26, 2001
Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's diseaseUlla Feldt-Rasmussen, Roger Abs, Bengt-Ake Bengtsson, et al.
The Journal of Clinical Endocrinology and Metabolism|July 20, 2006
Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacementAntonia M Brooke, Leonila A Kalingag, Farideh Miraki-Moud, et al.
Pageof 7